Immunity, Vaccines, and Cancer Practice Test 2026 - Free Practice Questions and Comprehensive Study Guide

Cytotoxic antineoplastic drugs act best on cells that are actively dividing because they disrupt processes required for DNA synthesis and chromosome separation during the cell cycle. Cells in S-phase or M-phase are particularly vulnerable, so tumors—which often proliferate rapidly—are susceptible to these agents. However, this also means normal tissues with high turnover are affected, leading to common toxicities like bone marrow suppression and mucosal damage.

That’s why the correct idea is that these drugs are most active against rapidly dividing cells, both normal and malignant. Slow-growing cells spend less time in vulnerable phases and are less affected. They aren’t exclusive to malignant cells, and immune cells can be targeted too when they’re actively dividing.